Amedisys, Inc. (AMED) Misses Q1 EPS by 6c; Guides Well Below the Street
Tweet Send to a Friend
Amedisys, Inc. (NASDAQ: AMED) reported Q1 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
